Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: nab-paclitaxel
Sponsor: Chinese Academy of Medical Sciences